6月2日中午12:00，仁醫(yī)醫(yī)療三人團(tuán)隊(duì)前往海德堡大學(xué)附屬醫(yī)院，拜訪了眼科主任Auffarth教授。他為我們的到訪精心準(zhǔn)備了會(huì)議室、巧克力、甜點(diǎn)和咖啡，熱情又周到。會(huì)議室里陳列著許多古籍，其中一些甚至已有400年的歷史。教授告訴我們，海德堡大學(xué)附屬醫(yī)院眼科已有200年歷史，是德國最具聲望和規(guī)模的眼科中心之一。海德堡眼科不僅是德國最早建立的大學(xué)眼科之一，也是歐洲領(lǐng)先的臨床與科研機(jī)構(gòu)，幾乎涵蓋了眼科所有亞專業(yè)領(lǐng)域，包括白內(nèi)障與屈光手術(shù)、視網(wǎng)膜疾病、青光眼、角膜病、眼部腫瘤和小兒眼科等?？剖遗鋫湎冗M(jìn)的診療設(shè)備，擁有國際化的醫(yī)療團(tuán)隊(duì)，是德國和歐洲患者的重要就醫(yī)中心，也是一座國際學(xué)術(shù)交流的橋梁。Auffarth教授本人在人工晶體研發(fā)和屈光白內(nèi)障手術(shù)領(lǐng)域具有世界級(jí)影響力。他告訴我們，他指導(dǎo)中國博士生已超過20年，與多家中國頂尖大學(xué)醫(yī)院建立了穩(wěn)定的合作關(guān)系，其中不少學(xué)生回國后已成為大學(xué)醫(yī)院的主任或擔(dān)任重要職務(wù)。當(dāng)我們介紹仁醫(yī)醫(yī)療的臨床醫(yī)學(xué)博士項(xiàng)目和訪學(xué)項(xiàng)目時(shí)，Auffarth教授表達(dá)了濃厚的興趣。他特別看重我們能提前對(duì)博士候選人的學(xué)歷背景、語言能力等進(jìn)行專業(yè)審核。他提到，曾有自己親自篩選的中國申請(qǐng)人最終因?qū)W歷不被德國對(duì)外教育辦公室認(rèn)可而被海德堡大學(xué)拒絕，令人非常遺憾。他希望通過我們的專業(yè)支持，避免此類情況，提升整體申請(qǐng)效率和成功率。他現(xiàn)場確認(rèn)，每年將為仁醫(yī)醫(yī)療項(xiàng)目預(yù)留兩個(gè)博士名額。同時(shí)，他也確定將于2026年訪華，參加仁醫(yī)醫(yī)療主辦的第六屆中歐醫(yī)院管理與學(xué)科建設(shè)人才培養(yǎng)全球論壇。此外，他計(jì)劃今年夏天再次訪問中國，接受仁醫(yī)醫(yī)療“世界上偉大的醫(yī)生”欄目專訪，向中國年輕醫(yī)生和同行們分享他寶貴的職業(yè)洞見和人生經(jīng)驗(yàn)。

At 12:00 noon on June 2nd, the team of three from Gloryren arrived at the Heidelberg University Hospital to visit Prof. Auffarth, Director of the Department of Ophthalmology. His team had thoughtfully reserved a meeting room and prepared chocolates, biscuits, and coffee for our visit, demonstrating both warmth and attentiveness. The meeting room was adorned with many ancient books, some of which are even 400 years old. Prof. Auffarth shared with us that the Department of Ophthalmology at Heidelberg University Hospital has a history of 200 years and is one of the most prestigious and largest ophthalmology centers in Germany. The Department of Ophthalmology at Heidelberg University Hospital is not only one of the earliest university-affiliated ophthalmology departments in Germany, but also a leading clinical and research institution in Europe. It covers almost all subspecialties of ophthalmology, including cataract and refractive surgery, retinal diseases, glaucoma, corneal diseases, ocular tumors, and pediatric ophthalmology. The department is equipped with advanced diagnostic and treatment equipment and boasts an international medical team. It is an important medical center for patients in Germany and Europe and also serves as a bridge for international academic exchanges. Prof. Auffarth himself has world - class influence in the fields of intraocular lens research and development and refractive cataract surgery. He told us that he has been supervising Chinese doctoral students for more than 20 years and has established stable cooperative relationships with many top university hospitals in China. Many of his students have become directors or held important positions at university hospitals after returning to China. When we introduced Gloryren’s German MD Program and Visiting Professor Program, Prof. Auffarth showed great interest. He particularly values our ability to conduct professional pre-screening of doctoral candidates' educational backgrounds and language proficiency. He mentioned that there were cases where Chinese applicants he personally selected were ultimately rejected by the University of Heidelberg because their educational qualifications were not recognized by the Central Office for Foreign Education (ZAB), which was very regrettable. He hopes that with our professional support, such situations can be avoided, and the overall application efficiency and success rate can be improved. He told us that there are two open positions in his lab every year, and would be happy to host possible candidates recommended by Gloryren. At the same time, he also confirmed that he will visit China in 2026 to participate in the 6th Sino-Euro Global Forum on Hospital Management, Specialty Construction & Talent Cultivation hosted by Gloryren. And he will visit China again in this summer and will attend Gloryren’s interview program - The World’s Great Doctors, sharing his valuable professional insights and life experiences with young Chinese doctors and peers.